Amanote Research
Register
Sign In
Will Europe Be Ready for the Treatment of Alzheimer's Disease?
The Lancet Neurology
- United Kingdom
doi 10.1016/s1474-4422(18)30409-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Neurology
Date
December 1, 2018
Authors
Unknown
Publisher
Elsevier BV
Related search
fMRI Beyond the Clinic: Will It Ever Be Ready for Prime Time?
PLoS Biology
Immunology
Molecular Biology
Genetics
Biochemistry
Microbiology
Biological Sciences
Agricultural
Neuroscience
The Future of Alzheimer's Disease Treatment
Aging Health
NICE Guidelines and the Treatment of Alzheimer's Disease: Evidence-Based Medicine May Be Discriminatory
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease
International Journal of Alzheimer's Disease
Aging
Cognitive Neuroscience
Molecular Neuroscience
Neurology
Behavioral Neuroscience
Cellular
Potential Repurposing of Oncology Drugs for the Treatment of Alzheimer's Disease
BMC Medicine
Medicine
Rare Disease Landscape: Will the Blockbuster Model Be Replaced?
Expert Opinion on Orphan Drugs
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
Lack of Support for Bexarotene as a Treatment for Alzheimer's Disease
Neuropharmacology
Molecular Neuroscience
Cellular
Pharmacology
Review of the Evidence That Transcranial Electromagnetic Treatment Will Be a Safe and Effective Therapeutic Against Alzheimer’s Disease
Journal of Alzheimer's Disease
Gerontology
Clinical Psychology
Mental Health
Psychiatry
Geriatrics
Medicine
Neuroscience